Institut de Science et d'Ingénierie Supramoleculaires, Université de Strasbourg, CNRS (UMR7006), Strasbourg, France.
Curr Top Med Chem. 2009;9(15):1419-35. doi: 10.2174/156802609789895665.
Heat shock protein 90 (Hsp90) is an ATP-dependent chaperone which is involved in the post-translational maturation and stabilization of over one hundred proteins ("its clients"). In the absence of Hsp90's chaperoning, its clients are misfolded and degraded via ubiquitin-proteasome pathway. It has become the focus of intense drug discovery efforts as its activity has been implicated in diverse pathologies ranging from oncology to neurodegenerative and infectious diseases. The most promising inhibitors reported to date inhibit the ATPase activity by binding to the N-terminal ATP pocket. Radicicol, a member of the resorcylic acid lactones (RALs), represents an important pharmacophore to this end. Efforts towards the development of this pharmacophore and its SAR are reviewed herein.
热休克蛋白 90(Hsp90)是一种依赖于 ATP 的伴侣蛋白,参与超过一百种蛋白质(“其客户”)的翻译后成熟和稳定。在没有 Hsp90 伴侣的情况下,其客户会通过泛素-蛋白酶体途径发生错误折叠和降解。由于其活性与从肿瘤学到神经退行性和传染病等多种病理学有关,因此它已成为药物发现的重点。迄今为止报道的最有前途的抑制剂通过与 N 端 ATP 口袋结合来抑制 ATP 酶活性。雷地昔醇是一种 Resorcylic 酸内酯(RALs)的成员,是此类抑制剂的重要药效团。本文综述了该药效团及其 SAR 的开发工作。